|
|
||||||||
Eur J Cardiothorac Surg 2003;23:633-636
© 2003 Elsevier Science NL
a Department of Cardiothoracic Surgery, The Northern General Hospital, Herries Road, Sheffield S5 7AU, UK
b Department of Histopathology, The Northern General Hospital, Herries Road, Sheffield S5 7AU, UK
Received 9 October 2002; received in revised form 23 November 2002; accepted 27 November 2002.
* Corresponding author. Tel.: +44-114-271-4954; fax: +44-114-261-0350
e-mail: graham.cooper{at}sth.nhs.uk
| Abstract |
|---|
|
|
|---|
Key Words: Cerebral protection Cell saver Cardiotomy suction Fat emboli
| 1. Introduction |
|---|
|
|
|---|
Diffuse intravascular fat emboli have been observed in the brains of patients who die after post-operative neurological complications early after cardiopulmonary bypass [5]. And fat emboli have therefore been implicated in post-operative neuropsychological impairment [5].
During cardiopulmonary bypass shed blood within the pericardium contains fat from the sternal marrow and other cut surfaces. Traditionally this blood is salvaged by cardiotomy suction and returned to the patient after filtration by a 40 µm arterial line filter. Before arterial line filters were standard, neurological complications were found to be preventable by discarding all blood that overflowed from the heart [6]. The current 40 micron arterial line filters reduce emboli in the middle cerebral artery [2]. However in dogs, even when shed blood salvaged by cardiotomy suction is filtered through 25 µm filters, cardiotomy suction has been identified as a major source of cerebral lipid emboli [7].
Another option for recycling shed blood is a cell saver. Compared with cardiotomy suction, use of a cell saver in dogs undergoing cardiopulmonary bypass decreases cerebral lipid emboli [8]. However there is concern that cell savers cause increased fragmentation of erythrocytes and removal of platelets [9,10].
This prospective randomised control trial compares the efficacy of cell saver with cardiotomy suction for removing fat from shed blood during cardiopulmonary bypass.
| 2. Methods and materials |
|---|
|
|
|---|
A Haemonetics Cell Saver 5 was used, with a 3-l capacity cell saver collection reservoir and a 125 ml wash bowl. The centrifuge speed was 5650 rpm. The washing solution was 500 ml of normal saline and the wash cycle lasted 1 min. The cell saver circuit was heparinised with 30 000 units of heparin in 1litre of normal saline.
A Polystan softshell cardiotomy reservoir with a 30 µm filter was connected into the cardiotomy suction line after the roller pump and before the main venous reservoir. The exit port of the cardiotomy reservoir was clamped to enable samples to accumulate for sampling. This allowed sampling before and after the filter, prior to dilution of salvaged blood by venous return in the main venous reservoir.
For the cell saver group, samples were taken before blood entered the cell saver reservoir. The post-cell saver sample was collected from an exit port of the cell saver blood bag. Prior to collection of the post process sample, the cardiotomy reservoir or cell saver blood bag was agitated to overcome any possible settling of blood.
Eight ml of blood was removed before and after the cardiotomy filter or cell saver process. All samples were centrifuged at 3000 rpm at 4°C for 15 min. The presence of visual fat on the surface was graded from 0 to 3 by an observer blinded to the source of samples (0=no fat, 1=fat visible, 2=a distinct layer of fat, 3=a thick layer of fat).
The top 1 ml of supernatant including the visible fat layer was removed from each sample. It was filtered under suction through a 25 mm diameter Whatman cellulose nitrate membrane filter with 5 µm pores and flushed through with 0.5 ml of water. Filters were dried on glass slides in boxes half full of desiccant at 4°C until constant weight. Filters were weighed to calculate the weight of fat per 8 ml blood sample. For each patient the percentage reduction in fat weight achieved by cardiotomy filter or cell saver was calculated.
For two random patients in each group an additional 6 ml was taken before and after the cardiotomy filter or cell saver and decanted into a separate test tube for observation by a histopathologist. After centrifugation of these histopathology samples, cytology slides of the fat layer were prepared and stained with Oil Red O and Sudan Black to confirm that it was indeed fat.
Chest drains were removed on the 1st post-operative day, when drainage was less than 20 ml an hour for 3 consecutive h.
Analysis of data was performed using Microsoft Excel and the SPSS 11 statistical package. Proportions were compared with a
2 test. Continuous normally distributed data was compared with a student t test and non-parametric data with a MannWhitney U-test. Actual P-values are reported.
| 3. Results |
|---|
|
|
|---|
|
|
The median weight of fat after cell saver process was 0.5 mg (0.10.9 mg) compared to 2.9 mg (1.34.5 mg) in the cardiotomy suction group (P<0.0001). For each patient the percentage reduction in fat weight achieved by cardiotomy suction or cell saver was calculated. Cell saver resulted in an 87% reduction compared to 45% with cardiotomy suction (P=0.007) (Fig. 2) .
|
| 4. Discussion |
|---|
|
|
|---|
There is concern that cell saver suction may result in increased haemolysis and removal of platelets compared with cardiotomy suction. Reents et al found increased levels of free haemoglobin and less platelets with cell saver suction compared with cardiotomy suction [10]. However Reents does not discuss any clinical significance of these findings. We found no difference between the two groups regarding post-operative haemoglobin, post operative blood loss, requirement for blood transfusions, or blood products, or the need for re-exploration for bleeding.
Cell saver use has other advantages including the removal of leukocytes activated by cardiopulmonary bypass which contribute to whole body inflammation.
The main limitation of cell saver use is that unlike cardiotomy suction, rapid return of shed blood to patients is not possible. However use of cell saver does not preclude use of cardiotomy suction if required. Other disadvantages include increasing cost of the procedure, and loss of platelets. This may be particularly important in patients with lower than normal platelet counts in whom may coagulation may be impaired.
The main limitation of this study is that the neurological outcome of the two groups were not assessed. However, this was a proof of concept study. A larger study addressing clinical outcomes is required.
| 5. Conclusion |
|---|
|
|
|---|
| Acknowledgments |
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
O. Fabre, A. Vincentelli, D. Corseaux, F. Juthier, S. Susen, A. Bauters, E. Van Belle, F. Mouquet, T. Le Tourneau, C. Decoene, et al. Comparison of blood activation in the wound, active vent, and cardiopulmonary bypass circuit. Ann. Thorac. Surg., August 1, 2008; 86(2): 537 - 541. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Djaiani, L. Fedorko, M. A. Borger, R. Green, J. Carroll, M. Marcon, and J. Karski Continuous-Flow Cell Saver Reduces Cognitive Decline in Elderly Patients After Coronary Bypass Surgery Circulation, October 23, 2007; 116(17): 1888 - 1895. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Appelblad and K. G. Engstrom Fat content in pericardial suction blood and the efficacy of spontaneous density separation and surface adsorption in a prototype system for fat reduction J. Thorac. Cardiovasc. Surg., August 1, 2007; 134(2): 366 - 372. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.W. Mulholland, J.R. Anderson, G.J. Yarham, S. Tuladhur, I. Saed, and M.D. Oliver Miniature cardiopulmonary bypass--the Hammersmith experience. Perfusion, May 1, 2007; 22(3): 161 - 166. [Abstract] [PDF] |
||||
![]() |
The Society of Thoracic Surgeons Blood Conservatio, V. A. Ferraris, S. P. Ferraris, S. P. Saha, E. A. Hessel II, C. K. Haan, B. D. Royston, C. R. Bridges, R. S.D. Higgins, G. Despotis, et al. Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline Ann. Thorac. Surg., May 1, 2007; 83(5_Supplement): S27 - S86. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G. Shann, D. S. Likosky, J. M. Murkin, R. A. Baker, Y. R. Baribeau, G. R. DeFoe, T. A. Dickinson, T. J. Gardner, H. P. Grocott, G. T. O'Connor, et al. An evidence-based review of the practice of cardiopulmonary bypass in adults: A focus on neurologic injury, glycemic control, hemodilution, and the inflammatory response. J. Thorac. Cardiovasc. Surg., August 1, 2006; 132(2): 283 - 290.e3. [Full Text] [PDF] |
||||
![]() |
J. M Murkin Pathophysiological Basis of CNS Injury in Cardiac Surgical Patients: Detection and Prevention Perfusion, July 1, 2006; 21(4): 203 - 208. [Abstract] [PDF] |
||||
![]() |
A. Vincentelli, B. Jude, and S. Belisle Antithrombotic therapy in cardiac surgery: [Traitement antithrombotique en chirurgie cardiaque]. Can J Anesth, June 1, 2006; 53(6_suppl): S89 - S102. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Nollert, I. Schwabenland, D. Maktav, F. Kur, F. Christ, P. Fraunberger, B. Reichart, and C. Vicol Miniaturized Cardiopulmonary Bypass in Coronary Artery Bypass Surgery: Marginal Impact on Inflammation and Coagulation but Loss of Safety Margins Ann. Thorac. Surg., December 1, 2005; 80(6): 2326 - 2332. [Abstract] [Full Text] [PDF] |
||||
![]() |
J W Mulholland The Great Britain and Ireland perspective: current perfusion safety issues, preparing for the future Perfusion, July 1, 2005; 20(4): 217 - 225. [Abstract] [PDF] |
||||
![]() |
A. J. de Vries, Y. J. Gu, Y. L. Douglas, W. J. Post, H. Lip, and W. van Oeveren Clinical evaluation of a new fat removal filter during cardiac surgery Eur. J. Cardiothorac. Surg., February 1, 2004; 25(2): 261 - 266. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G. Engstrom Contaminating fat in pericardial suction blood: a clinical, technical and scientific challenge Perfusion, January 1, 2004; 19(1_suppl): S21 - S31. [Abstract] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |